Alexander Hold (62), a former TV judge and current vice president of the Bavarian state parliament, is suffering from prostate cancer. “The carcinoma has already grown so close to the neighboring nerves that the operation becomes difficult. What additional treatment methods will be needed later will become clear after the operation,” said the Free Voters politician in Munich on Friday.

The cancer was discovered during a check-up

He reported that a routine preventive examination initially identified suspicious values ​​and an inconclusive finding. The cancer was only discovered after several additional tests. The prostate affected by the malignancy should be surgically removed in April.

“I was like most people: you suppress the possibility of getting a serious illness, and given the variety of everyday stresses, you don't think enough about the fact that you can't take health for granted. “The impact that such a diagnosis triggers is all the greater,” he emphasized.

“Please take precautions”

Despite the diagnosis, he is “very confident about the future. I generally have a very good immune system and a positive attitude,” Hold said. he points out the dangers of cancer: “Whether it's breast, urological, colon or skin cancer – get early and regular preventive care! With all types of cancer, the earlier something is detected, the better the chances of recovery.”

Since 2018, Hold has been a member of the Parliament of Free Electors of the Land of Bavaria. A year earlier, his party had even nominated him for the federal presidential election, albeit without a chance. He previously achieved national fame with the Sat.1 program “Richter Alexander Hold”.

Prostate cancer is the most common cancer among men in Germany. As with all types of cancer, early detection increases the chances of a cure. Almost 90 percent of victims in Germany survive. Despite this, more than 15,000 men die of prostate cancer in Germany every year. With a share of about 11.6 percent, prostate cancer is the second leading cause of cancer deaths among men in Germany, after lung cancer.